ArticleCancers2022

Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus Nivolumab.

Viktoria Stühler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.